受强制性开放获取政策约束的文章 - Jonathan J. Darrow了解详情
无法在其他位置公开访问的文章：21 篇
FDA regulation and approval of medical devices: 1976-2020
JJ Darrow, J Avorn, AS Kesselheim
Jama 326 (5), 420-432, 2021
强制性开放获取政策： Arnold Ventures LLC
The US biosimilar market: stunted growth and possible reforms
A Sarpatwari, R Barenie, G Curfman, JJ Darrow, AS Kesselheim
Clinical Pharmacology & Therapeutics 105 (1), 92-100, 2019
强制性开放获取政策： Arnold Ventures LLC
Speed, safety, and industry funding—from PDUFA I to PDUFA VI
JJ Darrow, J Avorn, AS Kesselheim
New England Journal of Medicine 377 (23), 2278-2286, 2017
强制性开放获取政策： Arnold Ventures LLC
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
L Pregelj, TJ Hwang, DC Hine, EB Siegel, RT Barnard, JJ Darrow, ...
Health Affairs 37 (5), 724-731, 2018
强制性开放获取政策： Arnold Ventures LLC
Patent term restoration for top-selling drugs in the United States
RF Beall, JJ Darrow, AS Kesselheim
Drug Discovery Today 24 (1), 20-25, 2019
强制性开放获取政策： Arnold Ventures LLC
Efficacy and costs of spinal muscular atrophy drugs
JJ Darrow, M Sharma, M Shroff, AK Wagner
Science Translational Medicine 12 (569), eaay9648, 2020
强制性开放获取政策： Arnold Ventures LLC
Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs
JJ Darrow, JE Chong, AS Kesselheim
bmj 369, 2020
强制性开放获取政策： Arnold Ventures LLC
Promoting competition to address pharmaceutical prices
J Darrow, AS Kesselheim
Health Affairs. March 15, 2018
强制性开放获取政策： Arnold Ventures LLC
Physicians’ Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey: Study examines physicians’ perspectives, gathered from a national survey, on FDA …
SS Dhruva, AS Kesselheim, S Woloshin, RZ Ji, Z Lu, JJ Darrow, ...
Health Affairs 43 (1), 27-35, 2024
强制性开放获取政策： Arnold Ventures LLC
Comparing onset of biosimilar versus generic competition in the United States
RF Beall, PE Ronksley, J Wick, JJ Darrow, A Sarpatwari, AS Kesselheim
Clinical Pharmacology & Therapeutics 108 (6), 1308-1314, 2020
强制性开放获取政策： Arnold Ventures LLC
Beyond The High Prices Of Prescription Drugs: A Framework To Assess Costs, Resource Allocation, And Public Funding: Commentary provides a comprehensive framework for …
JJ Darrow, DW Light
Health Affairs 40 (2), 281-288, 2021
强制性开放获取政策： Arnold Ventures LLC
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: An evaluation of Food and Drug Administration flexibilities
JJ Darrow, M Najafzadeh, K Stefanini, AS Kesselheim
The Lancet Infectious Diseases 20 (7), e159-e164, 2020
强制性开放获取政策： US National Institutes of Health, Arnold Ventures LLC
Discovery and Development of Pregabalin (Lyrica) The Role of Public Funding
R Barenie, J Darrow, J Avorn, AS Kesselheim
Neurology 97 (17), e1653-e1660, 2021
强制性开放获取政策： Arnold Ventures LLC
Strategies to manage drugs and devices approved based on limited evidence: results of a modified Delphi panel
SS Dhruva, JJ Darrow, AS Kesselheim, RF Redberg
Clinical Pharmacology & Therapeutics 111 (6), 1307-1314, 2022
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs, Arnold …
Two views of cancer medicines: Imagery versus evidence
JJ Darrow
Health Marketing Quarterly 40 (2), 141-152, 2023
强制性开放获取政策： US National Institutes of Health, Arnold Ventures LLC
Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimes
BS Walsh, JJ Darrow, AS Kesselheim
Nature Biotechnology 40 (2), 167-169, 2022
强制性开放获取政策： US National Institutes of Health, Arnold Ventures LLC
Understanding when real world data can be used to replicate a clinical trial: A cross‐sectional study of medications approved in 2011
M Fralick, E Bartsch, JJ Darrow, AS Kesselheim
Pharmacoepidemiology and Drug Safety 29 (10), 1273-1278, 2020
强制性开放获取政策： Canadian Institutes of Health Research, Arnold Ventures LLC
Government pharmaceutical development to address high prices: challenges ahead
JJ Darrow
Therapeutic Innovation & Regulatory Science 55 (5), 1103-1105, 2021
强制性开放获取政策： Arnold Ventures LLC
Vaccine Messaging by the FDA: A National Randomized Survey Study
WB Feldman, LZ Rand, D Carpenter, EG Campbell, JJ Darrow, ...
Journal of General Internal Medicine, 1-5, 2024
强制性开放获取政策： Arnold Ventures LLC
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval
JJ Darrow, V Van de Wiele, B Brown, AS Kesselheim
nature biotechnology 42 (9), 1350-1355, 2024
强制性开放获取政策： Arnold Ventures LLC
出版信息和资助信息由计算机程序自动确定